Glycemic monitoring with CGMs, glucose-lowering agents (GLP-1 receptor agonists), innovative insulin delivery systems, and mental health check-ins are just a few updates to the ADA 2025 Standards of Care.
Read More
If you’ve ever wondered which age, sex, ethnicity, or country has the highest diagnosis of type 1 diabetes, we have the most updated facts and figures.
Our friendly team would love to hear from you.